SpyGlass Pharma Inc., an Aliso Viejo-based late-stage biopharmaceutical company, today announced the appointment of Shannon Treviño as general counsel.
Prior to SpyGlass, Treviño was general counsel and corporate secretary at Inari Medical, which was acquired by Stryker Corp. for $4.9 billion last year. She was also an attorney at Sugg Law Group and spent eight years as clinical professor and director of the Transactional Lawyering Institute at Loyola Marymount University’s Law School.
“We are delighted to welcome Shannon to our growing team. She is a proven leader with a track record of guiding complex organizations through periods of growth,” SpyGlass Chief Executive Patrick Mooney said in a statement.
Shares in SpyGlass rose 2.7% to $18.93 apiece and a $633 million market cap (Nasdaq: SGP).
Related links:
